| |
| Issue |
Title |
| |
| Vol 30, No 9 (2025) |
Potential of lipid-lowering therapy in patients with acute coronary syndrome and severe dyslipidemia: effectiveness within lipid center, impact on prognosis |
Abstract
PDF (Rus)
|
|
A. A. Nekrasov, E. S. Timoshchenko, F. N Muradova, N. E Zvartau, A. S Aliyeva, T. A Nekrasova, A. A Modelkina, A. S Shchetkina, E. S Kuzyakina |
| |
| Vol 30, No 9 (2025) |
Ticagrelor monotherapy as a strategy to reduce the bleeding risk in patients with acute coronary syndrome who underwent percutaneous coronary intervention |
Abstract
PDF (Rus)
|
|
Yu. O. Shalaginova, R. M. Shakhnovich |
| |
| Vol 30, No 9 (2025) |
Monitoring and treatment of dyslipidemia in patients with high, very high and extreme cardiovascular risk in the North Caucasus Federal District |
Abstract
PDF (Rus)
|
|
I. B. Tuaeva, I. V. Terentyeva, M. A. Ibragimov, M. U. Totushev, E. A. Apsheva, L. R. Dzhanibekova |
| |
| Vol 30, No 7 (2025) |
Bioequivalence study of Rosuvastatin in healthy volunteers after a single dose on an empty stomach |
Abstract
PDF (Rus)
|
|
Yu. V. Kotovskaya, I. P. Malaya, A. V. Grigoriev, A. A. Sidorova, V. A. Stepanov, S. V. Ponasenkova |
| |
| Vol 30, No 6 (2025) |
Safety of prehospital thrombolysis with non-immunogenic staphylokinase in 51021 patients with ST-elevation myocardial infarction: data from the FRIDOM-registry |
Abstract
PDF (Rus)
|
|
S. N. Tereshchenko, S. F. Bagnenko, V. A. Markov, A. G. Miroshnichenko, I. I. Serebrennikov, S. O. Krylov, A. N. Lishchenko, S. M. Gorbacheva, V. V. Kuznetsov, L. A. Ostroumova, A. B. Ikhaev, D. V. Duplyakov, Zh. Yu. Chefranova, S. L. Konstantinov, E. V. Vyshlov, E. A. Ponomarev, R. M. Rabinovich, M. A. Petrushin, V. A. Kutsenko, A. G. Koledinsky, N. L. Vyazova, G. I. Stryabkova, T. M. Uskach, I. P. Minnullin, N. I. Gaponova, I. G. Trukhanova, L. V. Prokhasko, S. I. Mukhin, V. V. Kostylev, O. V. Krause, L. P. Belova, E. V. Lesnikov, G. P. Zhukov, S. A. Pribylov, A. V. Farsiyants, A. V. Zhirov, O. A. Shtegman, V. B. Ivanov, E. S. Timoshchenko, E. L. Makarov, O. A. Tolstoy, D. Yu. Sachkov, I. M. Karamova, A. R. Rakhmatullin, V. B. Kostogryz, E. S. Volkov, E. V. Rukosuev, E. P Yurkin, R. M. Shakhnovich, I. S. Yavelov, A. D. Erlikh, S. V. Ivanov, A. M. Semenov, M. P. Semenov, E. B. Yarovaya, S. S. Markin |
| |
| Vol 30, No 6 (2025) |
Antihypertensive and hypolipidemic efficacy of triple fixed-dose combinations based on perindopril: INTEGRATION II study |
Abstract
PDF (Rus)
|
|
A. O. Nedoshivin |
| |
| Vol 30, No 6 (2025) |
Efficacy of P2Y12 receptor blockers: current approaches and prospects |
Abstract
PDF (Rus)
|
|
A. S. Anisimova, E. Yu. Vasilyeva |
| |
| Vol 30, No 6 (2025) |
Comparative study of clinical efficacy of biosimilar Nektelisa (tenecteplase) based on randomized clinical trial |
Abstract
PDF (Rus)
|
|
M. M. Agirov, I. E. Adzeriho, E. N. Isaeva, S. G. Kalinina, V. V. Kashtalap, S. L. Konstantinov, O. M. Lapin, A. Yu. Luganova, A. M. Pristrom, I. P. Roshkaeva, V. V. Ryabov, T. V. Supryadkina, L. A. Khaisheva, L. A. Shpagina, E. P. Yurkin |
| |
| Vol 30, No 6 (2025) |
Anticoagulant therapy for atrial fibrillation and high risk of thromboembolic events in certain Russian regions in 2023 |
Abstract
PDF (Rus)
|
|
M. A. Druzhilov, O. Yu. Druzhilova, T. Yu. Kuznetsova, D. V. Gavrilov |
| |
| Vol 30, No 5 (2025) |
Coadministration of Cardiomagnyl with Edarbi/Edarbi Clo in comparison with enteric-coated acetylsalicylic acid and renin-angiotensin-aldosterone system blockers in patients with hypertension and atherosclerotic cardiovascular diseases in the Russian Federation. Results of the CARAT study |
Abstract
PDF (Rus)
|
|
F. T. Ageev, M. D. Smirnova, A. N. Kaftanov, D. V. Gavrilov |
| |
| Vol 30, No 5 (2025) |
Anticoagulant therapy in patients with ischemic stroke and atrial fibrillation (data from the registry of internal medicine departments of multidisciplinary hospitals of the North Caucasus Federal District) |
Abstract
PDF (Rus)
|
|
Z. A. Alimova, A. A. Bykova, Z. K. Salpagarova, F. R. Greve, A. L. Syrkin, N. A. Novikova |
| |
| Vol 30, No 4 (2025) |
Cost-effectiveness of using sodium-glucose cotransporter type 2 inhibitors as a part of therapy for cardiovascular death prevention and achieving the Reduction of Cardiovascular Mortality indicator of the Healthcare Development state program in patients with chronic kidney disease and resistant hypertension |
Abstract
PDF (Rus)
|
|
M. V. Zhuravleva, Yu. V. Gagarina, T. V. Marin |
| |
| Vol 30, No 4 (2025) |
Lipid profile changes in patients with acute leukemia after pathogenetic therapy |
Abstract
PDF (Rus)
|
|
E. A. Praskurnichy, V. О. Dzidzaria, Yu. S. Kitaeva |
| |
| Vol 30, No 3 (2025) |
Prospects for a pharmacoinvasive strategy in ST-elevation myocardial infarction in the Russian Federation |
Abstract
PDF (Rus)
|
|
V. E. Oleynikov, R. M. Shakhnovich, A. N. Yakovlev, R. M. Rabinovich, I. V. Avdeeva |
| |
| Vol 30, No 3 (2025) |
Efficacy and safety of inclisiran, evolocumab and alirocumab in patients with high, very high and extreme cardiovascular risk |
Abstract
PDF (Rus)
|
|
N. G. Lozhkina, N. P. Dobrovolskaya, S. N. Artemenko, M. V. Shipunov, A. D. Sharonin, V. A. Koltyugina, V. S. Timofeev, M. I. Voyevoda |
| |
| Vol 30, No 3 (2025) |
Comparative effectiveness of combined antihypertensive and psychocorrective therapy in hypertensive men with anxiety and depressive disorders in the andropause period |
Abstract
PDF (Rus)
|
|
O. V. Timofeeva, V. V. Skibitsky, A. V. Fendrikova |
| |
| Vol 30, No 3 (2025) |
Efficacy of transcatheter low-dose thrombolysis in patients with intermediate-high risk pulmonary embolism. Study rationale and design |
Abstract
PDF (Rus)
|
|
M. A. Simakova, S. I. Parkhomenko, K. B. Lapshin, T. D. Glebovskay, D. V. Karpova, K. N. Malikov, Ekaterina Leonidovna Urumova, A. V. Berezina, D. D. Zubarev, N. V. Marukyan, O. M. Moiseeva |
| |
| Vol 30, No 2 (2025) |
Efficacy of buffered acetylsalicylic acid and enteric-coated acetylsalicylic acid on platelet aggregation in patients with chronic coronary syndrome and type 2 diabetes (CASCADE): single-center observational comparative study |
Abstract
PDF (Rus)
|
|
Zh. D. Kobalava, A. S. Pisaryuk, A. A. Filkova, E. S. Tukhsanboev, A. N. Amirova, A. D. Korneichuk, G. S. Pavlikov, L. R. Burkhanova, I. A. Meray, M. A. Panteleev, A. N. Sveshnikova |
| |
| Vol 30, No 2 (2025) |
Comparative clinical and laboratory study of rivaroxaban and its generic forms in patients with stable coronary artery disease |
Abstract
PDF (Rus)
|
|
N. V. Lomakin, I. Yu. Tkach, E. A. Shirokov |
| |
| Vol 30, No 2 (2025) |
Non-immunogenic staphylokinase in patients with massive intermediate-high risk pulmonary embolism: protocol of the FORPE-2 multicenter, double-blind, randomized, placebo-controlled trial |
Abstract
PDF (Rus)
|
|
S. N. Tereshchenko, E. B. Yarovaya, S. G. Leontiev, I. S. Yavelov, R. M. Shakhnovich, A. D. Erlikh, T. M. Uskach, D. V. Duplyakov, V. A. Kutsenko, O. E. Ivlev, A. G. Soplenkova, A. M. Semenov, M. P. Semenov, S. V. Ivanov, S. S. Markin |
| |
| Vol 30, No 1 (2025) |
Efficacy of buffered and enteric-coated acetylsalicylic acid on platelet aggregation in patients with stable coronary artery disease and type 2 diabetes (CASCADE): rationale and design of a single-center observational comparative study |
Abstract
PDF (Rus)
|
|
Zh. D. Kobalava, A. S. Pisaryuk, A. A. Filkova, E. S. Tukhsanboev, A. N. Amirova, A. D. Korneichuk, G. S. Pavlikov, L. R. Burkhanova, I. A. Meray, M. A. Panteleev, A. N. Sveshnikova |
| |
| Vol 29, No 12 (2024) |
Looking for an optimal antihypertensive combination. Focus on azilsartan medoxomil/chlorthalidone |
Abstract
PDF (Rus)
|
|
M. D. Smirnova, T. V. Fofanova, F. T. Ageyev |
| |
| Vol 29, No 10 (2024) |
Risk factors for non-adherence to oral anticoagulant therapy and the potential of their modification in patients with atrial fibrillation: a narrative literature review |
Abstract
PDF (Rus)
|
|
I. M. Felikov, V. V. Kashtalap |
| |
| Vol 30, No 1 (2025) |
Pathogenetic therapy of mitral valve prolapse |
Abstract
PDF (Rus)
|
|
E. G. Malev, S. V. Reeva, M. Yu. Omelchenko, L. B. Mitrofanova, E. V. Timofeev, N. N. Parfenova, E. B. Luneva |
| |
| Vol 29, No 9 (2024) |
Monomorphic premature ventricular contractions in patients without cardiac structural changes: clinical and prognostic significance and evaluation of therapy effectiveness (clinical and experimental study) |
Abstract
PDF (Rus)
|
|
A. I. Olesin, I. V. Konstantinova, N. N. Tyuteleva, Yu. S. Zueva, V. S. Ivanov, A. V. Koziy |
| |
| Vol 29, No 9 (2024) |
Problematic points of anticoagulant therapy for atrial fibrillation in certain Russian regions in 2016- 2019: results of a retrospective big data analysis |
Abstract
PDF (Rus)
|
|
M. A. Druzhilov, O. Yu. Druzhilova, Z. A. Ilchenko, P. I. Chalaya, T. Yu. Kuznetsova |
| |
| Vol 29, No 6 (2024) |
Effectiveness of inclisiran lipid-lowering therapy in patients with atherosclerotic cardiovascular disease in Moscow healthcare |
Abstract
PDF (Rus)
|
|
A. I. Sapina, Yu. Yu. Varlamova, M. G. Papyrina, A. S. Bezymyanny, E. L. Kordzaya, E. Yu. Vasilyeva |
| |
| Vol 29, No 6 (2024) |
Effectiveness of neoton in patients with heart failure receiving sacubitril/valsartan. Sub-analysis of the BYHEART study |
Abstract
PDF (Rus)
|
|
S. N. Tereshchenko, A. A. Safiullina |
| |
| Vol 28, No 8 (2023) |
Potential of anticoagulant therapy in cardiology practice for thrombocytopenia. Literature review |
Abstract
PDF (Rus)
|
|
K. G. Pereverzeva, S. S. Yakushin, A. An. Korshikova |
| |
| Vol 28, No 8 (2023) |
Patients with atrial fibrillation and a low risk of thromboembolic events: prescription rate of anticoagulant therapy according to a retrospective analysis |
Abstract
PDF (Rus)
|
|
M. A. Druzhilov, T. Yu. Kuznetsova |
| |
| Vol 28, No 10 (2023) |
New data from a subanalysis of the TRICOLOR study: antihypertensive effectiveness of the triple single-pill combination of amlodipine/indapamide/perindopril and predictors of effectiveness and blood pressure control in young patients |
Abstract
PDF (Rus)
|
|
Yu. A. Karpov, N. A. Logunova, B. B. Kvasnikov, Yu. V. Khomitskaya |
| |
| Vol 28, No 10 (2023) |
Modern algorithms for statin therapy |
Abstract
PDF (Rus)
|
|
V. A. Susekov |
| |
| Vol 27, No 12 (2022) |
Potential of primary drug prevention of cardiotoxicity in the context of anticancer therapy |
Abstract
PDF (Rus)
|
|
Yu. A. Vasyuk, E. Y. Shupenina, E. O. Novosel, D. A. Vyzhigin, A. G. Nosova, L. G. Zhukova, D. A. Filonenko, E. I. Khatkova |
| |
| Vol 27, No 12 (2022) |
Myocardial strain parameters and autonomic balance in various variants of the postinfarction course in patients receiving high-dose atorvastatin therapy |
Abstract
PDF (Rus)
|
|
V. E. Oleinikov, A. V. Golubeva, Yu. A. Barmenkova, A. V. Kulyutsin, N. V. Burko, M. V. Lukyanova, N. A. Donetskaya |
| |
| Vol 27, No 12 (2022) |
Prevalence of oral anticoagulant therapy in clinical practice in patients hospitalized with acute ischemic stroke |
Abstract
PDF (Rus)
|
|
E. V. Tavlueva, O. N. Savkova, E. V. Zernova, S. A. Berns, O. M. Drapkina |
| |
| Vol 28, No 1 (2023) |
Cardioprotective effect of thiotriazoline in cancer patients |
Abstract
PDF (Rus)
|
|
A. V. Koltsov, V. V. Tyrenko |
| |
| Vol 28, No 1 (2023) |
Influence of intravenous ferric carboxymaltose on non-invasive parameters of left ventricular myocardial work in patients with heart failure with reduced ejection fraction |
Abstract
PDF (Rus)
|
|
Zh. D. Kobalava, A. F. Safarova, A. A. Lapshin |
| |
| Vol 27, No 9 (2022) |
Ways to increase adherence to antihypertensive therapy |
Abstract
PDF (Rus)
|
|
S. A. Boytsov, Yu. A. Karpov, N. A. Logunova, Yu. P. Burtsev, B. B. Kvasnikov, Yu. V. Khomitskaya |
| |
| Vol 27, No 9 (2022) |
Hyperuricemia as a risk factor for cardiovascular events in hypertensive patients |
Abstract
PDF (Rus)
|
|
I. A. Libov, Yu. N. Moiseeva, A. G. Komarova |
| |
| Vol 27, No 7 (2022) |
Effectiveness of beta-blockers in the treatment of idiopathic premature ventricular contractions in children |
Abstract
PDF (Rus)
|
|
K. B. Alekseeva, T. K. Kruchina, M. Sh. Malyarova, G. A. Novik |
| |
| Vol 27, No 7 (2022) |
Potential of combination therapy in patients with hypertension and dyslipidemia |
Abstract
PDF (Rus)
|
|
T. V. Gorokhova, N. B. Perepech |
| |
| Vol 27, No 9 (2022) |
The effect of ticagrelor and clopidogrel on angiographic parameters according to diabetic status in patients with ST elevation myocardial infarction |
Abstract
PDF (Eng)
|
|
F. Aydınyılmaz, H. Sunman, E. Algül, A. Ö. Özkaya İbiş, N. B. Özbeyaz, İ. Guliyev, M. Erzurum, T. Çimen, M. Tulmaç |
| |
| Vol 27, No 1 (2022) |
Effectiveness of triple fixed-dose combination in patients with inadequate blood pressure control |
Abstract
PDF (Rus)
|
|
E. V. Zbyshevskaya, V. E. Gumerova, V. P. Erinchek, N. A. Logunova |
| |
| Vol 27, No 1 (2022) |
nticoagulant therapy monitoring in COVID-19 patients in the intensive care unit: thromboelastometry and echocardiography |
Abstract
PDF (Rus)
|
|
Yu. L. Ketsko, O. V. Tereshina |
| |
| Vol 26, No 12 (2021) |
Evaluation of the effect of the use of the drug ticagrelor in patients with acute coronary syndrome on achieving the target indicator “reduction of mortality from diseases of the circulatory system” in 2022-2024 |
Abstract
PDF (Rus)
|
|
M. V. Zhuravleva, S. K. Zyryanov, F. N. Paleev, A. N. Yakovlev, T. V. Marin, Yu. V. Gagarina |
| |
| Vol 26, No 12 (2021) |
Effect of dapagliflozin therapy on achieving cardiovascular mortality target indicators in patients with heart failure |
Abstract
PDF (Rus)
|
|
M. V. Zhuravleva, S. N. Tereshchenko, I. V. Zhirov, S. V. Villevalde, T. V. Marin, Yu. V. Gagarina |
| |
| Vol 26, No 12 (2021) |
Optimization of blood pressure control, organ protection and metabolic disorders using a fixed-dose combination of lisinopril+amlodipine+rosuvastatin in hypertensive patients after COVID-19 |
Abstract
PDF (Rus)
|
|
S. V. Nedogoda, A. A. Ledyaeva, E. V. Chumachek, V. V. Tsoma, A. S. Salasyuk, V. O. Lutova, E. A. Popova, D. S. Vlasov, O. I. Bychkova, V. A. Labaznikova, K. S. Evdokimov |
| |
| Vol 26, No 8 (2021) |
Comparative efficacy of medication and cardiac resynchronization therapy in patients with heart failure with reduced ejection fraction |
Abstract
PDF (Rus)
|
|
U. A. Eyyubova |
| |
| Vol 26, No 8 (2021) |
Optimal choice of prophylactic anticoagulant therapy for nonvalvular atrial fibrillation in the context of COVID-19 pandemic |
Abstract
PDF (Rus)
|
|
A. S. Polyakov, V. V. Tyrenko, E. V. Kryukov, Ya. A. Noskov |
| |
| Vol 26, No 9 (2021) |
Practical efficacy and safety of Konsilar D24 in patients with hypertension: data from the KONSONANS program |
Abstract
PDF (Rus)
|
|
A. O. Konradi, A. S. Galyavich, V. V. Kashtalap, Yu. M. Lopatin, N. P. Lyamina, S. V. Nedogoda, A. O. Nedoshivin, G. I. Nechaeva, L. G. Ratova, I. I. Shaposhnik |
| |
| Vol 26, No 7 (2021) |
Integrated solution for very high cardiovascular risk patients. Rationale and design of a pilot study |
Abstract
PDF (Rus)
|
|
E. I. Pavlyuk, M. V. Ionov, A. S. Alieva, N. G. Avdonina, A. N. Yakovlev, N. E. Zvartau |
| |
| Vol 26, No 7 (2021) |
Potential of valsartan+sacubitril therapy in hypertensive heart disease |
Abstract
PDF (Rus)
|
|
A. G. Ovchinnikov, A. D. Gvozdeva, A. V. Potekhina, M. V. Vitsenya, F. T. Ageev |
| |
| Vol 26, No 7 (2021) |
Efficiency and safety of various dual antiplatelet therapy strategies in patients undergoing percutaneous coronary intervention due to myocardial infarction |
Abstract
PDF (Rus)
|
|
S. B. Aksentiev, A. V. Solovieva, D. S. Yunevich |
| |
| Vol 26, No 5 (2021) |
A patient with atrial fibrillation and diabetes: selecting the optimal anticoagulant therapy regimen |
Abstract
PDF (Rus)
|
|
A. G. Obrezan, A. E. Filippov, A. A. Obrezan |
| |
| Vol 26, No 5 (2021) |
Effect of combination antihypertensive therapy, including renin-angiotensin-aldosterone system inhibitors, on oxidative stress and arterial remodeling in hypertensive patients with heart failure with preserved ejection fraction |
Abstract
PDF (Rus)
|
|
Z. M. Akhilgova, A. P. Roitman, N. G. Rakova, A. V. Bugrov, E. A. Pavlovskaya, M. S. Zastrozhin, A. G. Avtandilov |
| |
| Vol 26, No 5 (2021) |
Twenty-four-hour and office blood pressure measurement in a comprehensive assessment of the effectiveness of 12-week therapy with a triple fixed-dose combination of amlodipine/indapamide/perindopril in hypertensive patients in actual clinical practice |
Abstract
PDF (Rus)
|
|
V. M. Gorbunov, Yu. A. Karpov, E. V. Platonova, Ya. N. Koshelyaevskaya |
| |
| Vol 26, No 4 (2021) |
Phenotypic clusters in heart failure with preserved and mid-range ejection fraction: new data and perspectives |
Abstract
PDF (Rus)
|
|
O. V. Tsygankova, V. V. Veretyuk |
| |
| Vol 26, No 3 (2021) |
Effect of metformin therapy on muscle mass and strength in patients with and without diabetes. Meta-analysis of 15 studies |
Abstract
PDF (Rus)
|
|
A. V. Sokolova, A. V. Klimova, D. O. Dragunov, G. P. Arutyunov |
| |
| Vol 26, No 1 (2021) |
Effect of levosimendan on long-term prognosis in patients with myocardial infarction and concomitant chronic brain ischemia |
Abstract
PDF (Rus)
|
|
N. B. Lebedeva, L. Yu. Chesnokova, O. L. Barbarash |
| |
| Vol 26, No 1 (2021) |
Efficacy of sodium-glucose co-transporter-2 inhibitors in patients with heart failure |
Abstract
PDF (Rus)
|
|
E. V. Kovalenko, M. V. Lozhkina, G. G. Arabidze, V. G. Kryakushkin |
| |
| Vol 26, No 1 (2021) |
Effects of empagliflozin on exercise tolerance and left ventricular diastolic function in patients with heart failure with preserved ejection fraction and type 2 diabetes: a prospective single-center study |
Abstract
PDF (Rus)
|
|
A. G. Ovchinnikov, A. A. Borisov, K. Yu. Zherebchikova, O. Yu. Ryabtseva, A. D. Gvozdeva, V. P. Masenko, F. T. Ageev, S. A. Boytsov |
| |
| Vol 26, No 1 (2021) |
Early discontinuation of dual antiplatelet therapy via acetylsalicylic acid cessation in patients with acute coronary syndrome undergoing percutaneous coronary interventions to reduce the bleeding risk |
Abstract
PDF (Rus)
|
|
O. V. Averkov |
| |
| Vol 26, No 1 (2021) |
Pulse pressure and cognitive impairment |
Abstract
PDF (Rus)
|
|
O. D. Ostroumova, A. I. Kochetkov, T. M. Ostroumova |
| |
| Vol 26, No 2 (2021) |
Psychological continuum of elderly hypertensive patients with metabolic syndrome receiving chronotherapy with a fixed-dose combination of amlodipine, lisinopril and rosuvastatin |
Abstract
PDF (Rus)
|
|
N. M. Agarkov, O. I. Okhotnikov, S. I. Korneeva, E. O. Moskaleva, A. A. Moskalev, V. I. Kolomiec, A. M. Markelova, E. A. Markelova |
| |
| Vol 26, No 3 (2021) |
Diuretics for hypertension from the perspective of novel clinical guidelines and meta-analyzes |
Abstract
PDF (Rus)
|
|
S. V. Nedogoda |
| |
| Vol 26, No 3 (2021) |
The role of SGLT2 inhibitors beyond glucose-lowering to cardio-renal protection |
Abstract
PDF (Eng)
|
|
J. Karalliedde |
| |
| Vol 26, No 3 (2021) |
Promising areas of pharmacotherapy for obesity |
Abstract
PDF (Rus)
|
|
M. A. Druzhilov, T. Yu. Kuznetsova, G. A. Chumakova |
| |
| Vol 25, No 12 (2020) |
Effect of ticagrelor in patients with acute coronary syndrome on the achievement of the targets of federal project on the prevention of cardiovascular diseases: 3-year perspective estimates |
Abstract
PDF (Rus)
|
|
M. V. Zhuravleva, F. N. Paleev, S. K. Zyryanov, A. N. Yakovlev, T. V. Marin, Yu. V. Gagarina |
| |
| Vol 25, No 8 (2020) |
Cost analysis of dual antiplatelet therapy with prasugrel and ticagrelor in patients with acute coronary syndrome after percutaneous coronary intervention |
Abstract
PDF (Rus)
|
|
I. N. Dyakov, E. A. Ushkalova |
| |
| Vol 25, No 7 (2020) |
Changes in prescribing antithrombotic therapy in patients with atrial fibrillation and myocardial infarction in 2016-2019 |
Abstract
PDF (Rus)
|
|
K. G. Pereverzeva, S. S. Yakushin, M. S. Yakushina, A. V. Ezhova, I. A. Bogdanovich, L. A. Simkova |
| |
| Vol 25, No 7 (2020) |
Heart rate-lowering therapy in gout patients with stable coronary artery disease: focus on ivabradine |
Abstract
PDF (Rus)
|
|
N. N. Kushnarenko, T. A. Medvedeva, M. Yu. Mishko, T. M. Karavaeva |
| |
| Vol 25, No 7 (2020) |
Experience of using propafenone in newborns and young children with arrhythmias |
Abstract
PDF (Rus)
|
|
T. K. Kruchina, T. S. Kovalchuk, E. S. Vasichkina, B. A. Tatarsky |
| |
| Vol 25, No 7 (2020) |
Identification of potentially effective antiarrhythmic drugs to individualize premature ventricular contraction therapy in patients without structural cardiac changes |
Abstract
PDF (Rus)
|
|
A. I. Olesin, I. V. Konstantinova, Yu. S. Zueva, A. V. Koziy |
| |
| Vol 25, No 7 (2020) |
Choice of ventricular arrhythmia therapy in coronary artery disease |
Abstract
PDF (Rus)
|
|
A. A. Tatarinova, E. A. Ryngach, T. V. Treshkur |
| |
| Vol 25, No 7 (2020) |
Azilsartan medoxomil for improving insulin resistance and adipokine levels in hypertension in comparison with angiotensin-converting enzyme inhibitors |
Abstract
PDF (Rus)
|
|
S. V. Nedogoda, E. V. Chumachek, V. V. Tsoma, T. N. Sanina, A. S. Salasyuk, V. O. Smirnova, E. A. Popova |
| |
| Vol 25, No 7 (2020) |
Choice of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention |
Abstract
PDF (Rus)
|
|
A. N. Golosova, S. V. Gatsura, E. A. Ulyanova, Zh. Yu. Dvoryanchikova |
| |
| Vol 25, No 8 (2020) |
Effects of SGLT2 inhibitor dapagliflozin in patients with heart failure with reduced ejection fraction |
Abstract
PDF (Rus)
|
|
N. R. Khasanov |
| |
| Vol 25, No 9 (2020) |
Increment of the effectiveness of treating hypertension and dyslipidemia using a triple fixed-dose combination and the vascular age concept |
Abstract
PDF (Rus)
|
|
O. V. Tsygankova, T. I. Batluk, L. D. Latyntseva |
| |
| Vol 25, No 8 (2020) |
PCSK9 inhibitors for in-hospital treatment of patients with acute coronary syndrome and severe lipid metabolism disorders |
Abstract
PDF (Rus)
|
|
O. L. Barbarash, N. V. Fedorova, D. Yu. Sedykh, O. V. Gruzdeva, O. N. Khryachkova, V. V. Kashtalap, A. A. Filimonova |
| |
| Vol 25, No 7 (2020) |
Modern approaches to transvenous lead extraction |
Abstract
PDF (Rus)
|
|
D. G. Podolyak, A. Yu. Kiprensky, S. A. Mironovich |
| |
| Vol 25, No 6 (2020) |
Fixed-dose combination of amlodipine/indapamide/perindopril arginine — a rational and safe choice for blood pressure control in actual clinical setting: data of an observational program DOKAZATEL`STVO |
Abstract
PDF (Rus)
|
|
J. D. Kobalava, V. V. Tolkacheva, E. A. Troitskaya, I. A. Kolesnikova, M. A. Markova |
| |
| Vol 25, No 8 (2020) |
Effect of a combination of angiotensin-converting enzyme inhibitor and diuretic on the frequency and parameters of lower limb venous reflux in working-age men with hypertension |
Abstract
PDF (Rus)
|
|
S. V. Letyagina, V. M. Baev, S. A. Shmeleva, T. Yu. Agafonova |
| |
| Vol 25, No 2 (2020) |
Latent opportunities for the prevention of ischemic stroke in patients with atherosclerosis-related diseases: additional analysis of randomized trials on rivaroxaban |
Abstract
PDF (Rus)
|
|
S. R. Gilyarevskiy |
| |
| Vol 25, No 2 (2020) |
Myocardial contractility dysfunction in patients with chronic lymphocytic leukemia receiving chemotherapy and their treatment with enalapril |
Abstract
PDF (Rus)
|
|
I. L. Davydkin, T. P. Kuzmina, I. A. Zolotovskaya, O. V. Tereshina, O. E. Danilova, R. K. Khairetdinov, L. A. Rogozina |
| |
| No 7 (2019) |
Prediction of antiarrhythmic therapy effectiveness in children |
Abstract
PDF (Rus)
PDF (Eng)
|
|
L. I. Svintsova, O. Yu. Dzhaffarova, I. V. Plotnikova |
| |
| No 7 (2019) |
Effect of atorvastatin on the most important mechanisms of arrhythmogenesis in patients with ST-elevated myocardial infarction |
Abstract
PDF (Rus)
|
|
V. E. Oleynikov, M. V. Lukianova, E. V. Dushina, Yu. A. Barmenkova |
| |
| Vol 25, No 7 (2020) |
Cardiology Research Institute, Tomsk National Research Medical Center |
Abstract
PDF (Rus)
|
|
B. A. Tatarsky, N. V. Kazennova, R. E. Batalov, S. V. Popov |
| |
| No 5 (2019) |
Effect of atorvastatin and rosuvastatin on the PCSK9 blood concentration in statin-naive patients with atherosclerosis |
Abstract
PDF (Rus)
|
|
A. Yu. Filatova, T. I. Arefieva, E. A. Klesareva, O. I. Afanasieva |
| |
| No 5 (2019) |
Nicorandil in the prevention of cardiac damage and type 4A myocardial infarction with planned percutaneous coronary intervention in patients with atherosclerosis of coronary arteries |
Abstract
PDF (Rus)
|
|
G. N. Soboleva, R. V. Gostishchev, A. N. Rogoza, T. I. Kotkina, A. N. Samko |
| |
| No 6 (2019) |
Comparative analysis of antihypertensive effects of chlorthalidone and indapamide-retard in combination with azilsartan medoxomil in patients with arterial hypertension |
Abstract
PDF (Rus)
|
|
Zh. D. Kobalava, V. V. Kulakov, L. A. Goreva, S. V. Villevalde |
| |
| No 4 (2019) |
Current approaches to periprocedural anticoagulation treatment in patients undergoing atrial fibrillation ablation |
Abstract
PDF (Rus)
|
|
N. Z. Gasymova, E. N. Mikhailov |
| |
| No 3 (2019) |
Consequences of escalation and de-escalation of double antiplatelet therapy in patients with acute coronary syndrome in real clinical practice |
Abstract
PDF (Rus)
|
|
R. L. Shamraev, O. V. Ilyukhin, V. V. Ivanenko, S. G. Merzlyakov, Yu. M. Lopatin |
| |
| No 2 (2019) |
The effectiveness of trimetazidine and fabomotizole in the prevention of angina progression and improvement of life quality in patients in area of armed conflict |
Abstract
PDF (Rus)
|
|
Z. Yu. Shakhbiyeva, A. A. Abdullaev, U. A. Isiamova, D. D. Abdulpatakhov, A. A. Abdullaeva |
| |
| No 2 (2019) |
Contribution of anticoagulant therapy adherence to the risk of complications of atrial fibrillation |
Abstract
PDF (Rus)
|
|
Yu. P. Skirdenko, N. A. Nikolaev |
| |
| No 4 (2019) |
Strategies and methods for the correction of obesity and associated cardiovascular risk |
Abstract
PDF (Rus)
|
|
T. Yu. Kuznetsova, M. A. Druzhilov, G. A. Chumakova, N. D. Veselovskaya |
| |
| No 12 (2018) |
Efficacy and tolerance of Arifam in patients with arterial hypertension over 55 years old: main results of the observational program ARBALET |
Abstract
PDF (Rus)
|
|
Zh. D. Kobalava, V. V. Tolkacheva, N. Kh. Bagmanova, E. R. Khasanova |
| |
| No 12 (2018) |
Effective blood pressure reduction: results of the regional program “DOVERIE” |
Abstract
PDF (Rus)
|
|
N. V. Dobryninа, S. S. Yakushin |
| |
| No 4 (2019) |
Effects of benfotiamine on the insulin resistance state, some pro- and anti-inflammatory factors content in patients with type 2 diabetes mellitus and cardiac autonomic neuropathy |
Abstract
PDF (Eng)
|
|
V. A. Serhiyenko, A. A. Serhiyenko, V. B. Segin, S. Azhmi, L. M. Serhiyenko |
| |
| No 8 (2018) |
THE INFLUENCE OF HYPOLIPIDEMIC THERAPY ON THE LEVEL OF MODIFIED LOW DENSITY LIPOPROTEIDES |
Abstract
PDF (Rus)
|
|
V. Z. Lankin, A. K. Tikhaze, G. G. Konovalova |
| |
| No 8 (2018) |
CLINICAL ECONOMY EFFICACY OF TARGETED APPROACH TO ACUTE CORONARY SYNDROME PATIENTS MANAGEMENT WITH PERCUTANEOUS INTERVENTION |
Abstract
PDF (Rus)
|
|
L. V. Shukil, О. Yu. Korennova, S. P. Podolnaya, E. P. Prikhodko |
| |
| No 3 (2018) |
INFLUENCE OF TORASEMIDE ON ELECTRICAL INSTABILITY OF THE HEART IN PATIENTS WITH ISCHEMIC MITRAL REGURGITATION POST MYOCARDIAL INFARCTION |
Abstract
PDF (Rus)
|
|
I. B. Ibragimova, U. A. Islamova, R. M. Gafurova, A. A. Abdullaev |
| |
| No 3 (2018) |
CLOPIDOGREL RESPONSE IN ACUTE CORONARY SYNDROME PATIENTS WITH CYP2Y12*2 AND CYP2Y12*3 POLYMORPHISMS |
Abstract
PDF (Eng)
|
|
R. Rahmatini, G. Aliska, M. Syafri, A. Achyar |
| |
| No 3 (2018) |
AN EXPERIENCE OF TRIMETAZIDINE USAGE IN COMORBIDITY |
Abstract
PDF (Rus)
|
|
I. V. Kochetkova, T. M. Chernykh, G. M. Panyushkina |
| |
| No 12 (2017) |
INFLUENCE OF THE COMBINATION DRUG PRESTANS (PERINDOPRIL A, AMLODIPINE) ON MORPHO-FUNCTIONAL PARAMETERS OF ARTERIAL BED IN ESSENTIAL HYPERTENSION |
Abstract
PDF (Rus)
|
|
Yu. A. Danilogorskaya, E. A. Zheleznykh, E. V. Privalova, A. A. Shchendrygina, Yu. N. Belenkov, I. S. Ilgisonis, M. I. Tishman |
| |
| No 12 (2017) |
PULSE REDUCTION IN MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY (TWO CLINICAL CASES) |
Abstract
PDF (Rus)
|
|
N. S. Krylova, E. A. Kovalevskaya, N. G. Poteshkina, Е. A. Mershina, V. Е. Sinitsyn, N. A. Sonicheva, L. Monserrat |
| |
| No 12 (2017) |
MODERN OPPORTUNITIES FOR ANTIHYPERTENSION THERAPY: THE PLACE OF AZILSARTAN MEDOXOMIL |
Abstract
PDF (Rus)
|
|
V. V. Skibitsky, A. V. Fendrikova |
| |
| No 12 (2017) |
APPROACHES TO SELECTION OF ANTIHYPERTENSION DRUG WITHIN APPLIED LOWER TARGET BLOOD PRESSURE LEVELS |
Abstract
PDF (Rus)
|
|
S. R. Gilyarevsky, М. V. Golshmid, I. М. Kuzmina |
| |
| No 12 (2017) |
COMPARISON OF HEMODYNAMIC EFFECTS OF INHALATORY ILOPROST AND NITRIC OXIDE IN PATIENTS WITH SEVERE LEFT VENTRICLE DYSFUNCTION |
Abstract
PDF (Rus)
|
|
A. E. Bautin, A. S. Yakovlev, S. V. Zayashnikov, D. M. Tashkhanov, A. O. Marichev, P. A. Fedotov, M. А. Bortsova, Yu. V. Sazonova, I. V. Sukhova, I. E. Titova, M. A. Simonenko, M. Yu. Sitnikova, V. K. Novikov, O. M. Moiseeva |
| |
| No 11 (2017) |
ROLE OF GENDER SPECIFICS IN MYOCARDIAL REMODELLING, CARDIOVASCULAR COMPLICATIONS DEVELOPMENT AND EFFICACY OF PHARMACOTHERAPY IN HEART FAILURE PATIENTS AFTER CARDIAC SURGERY |
Abstract
PDF (Rus)
|
|
Yu. V. Liskova, А. А. Stadnikov, S. P. Salikova |
| |
| No 7 (2017) |
ADVANTAGES AND NOVELTY OF CLINICAL APPLICATION OF THE TRIPLE COMBINATION FOR ARTERIAL HYPERTENSION WITH DYSLIPIDEMIA: ACE INHIBITOR PERINDOPRIL WITH ROSUVASTATIN AND INDAPAMIDE |
Abstract
PDF (Rus)
|
|
M. L. Maksimov, A. S. Ermolaeva, O. V. Dralova |
| |
| No 7 (2017) |
PERSONALIZED APPROACH TO TREATMENT AND REHABILITATION OF CARDIOVASCULAR PATIENTS (ON THE MATERIALS OF ARTERIAL HYPERTENSION AND HEART FAILURE) |
Abstract
PDF (Rus)
|
|
E. S. Ternovaya, B. A. Volel, D. V. Troshina, V. V. Zakharov, F. Yu. Kopylov |
| |
| No 7 (2017) |
ATRIAL FIBRILLATION AND HEART FAILURE: APPROACHES TO ANTITHROMBOTIC THERAPY |
Abstract
PDF (Rus)
|
|
B. A. Tatarsky, S. V. Popov, N. V. Kazennova |
| |
| No 3 (2006) |
Comparative efficacy of ace inhibitor spirapril in hypertensive patients from various age groups |
Abstract
PDF (Rus)
|
|
L. A. Sokolova, P. P. Tichonov, V. N. Komelov |
| |
| No 3 (2006) |
Propafenone and amiodarone efficacy in paroxysmal atrial fibrillation treatment |
Abstract
PDF (Rus)
|
|
N. N. Isakova, Yu. V. Kulakov, A. M. Kononova, O. P. Modnova, L. M. Moldovanova, O. A. Moldovanova |
| |
| No 3 (2006) |
Long-term carvedilol therapy in patients with stage II arterial hypertension |
Abstract
PDF (Rus)
|
|
L. I. Markova, A. E. Radzevich |
| |
| No 1 (2006) |
Myocardial cytoprotection and ischemic myocardial dysfunction correction in stable angina patients after transluminal balloon angioplasty or coronary artery stenting |
Abstract
PDF (Rus)
|
|
I. G. Gordeev, V. A. Lusov, E. A. Bekchiu, N. A. Volov, E. E. Ilina, A. Yu. Lebedeva |
| |
| No 1 (2006) |
Spirapril therapy and its effects in arterial hypertension patients |
Abstract
PDF (Rus)
|
|
M. V. Leonova, M. A. Demidova, A. V. Tarasov, Yu. B. Belousov |
| |
| No 1 (2006) |
Neurocirculatory distonia: diagnostics and treatment |
Abstract
PDF (Rus)
|
|
O. N. Sivyakova, E. F. Konyuk |
| |
| No 4 (2005) |
Clinical equivalence of amlodipine medications in arterial hypertension patients |
Abstract
PDF (Rus)
|
|
L. I. Markova, A. E. Radzevich, G. D. Morgun |
| |
| No 4 (2005) |
Endothelial dysfunction in heart failure with normal systolic function, and its correction with a metabolic agent, mildronate |
Abstract
PDF (Rus)
|
|
V. P. Geychenko, A. V. Kuryata, O. V. Muzhchil |
| |
| No 4 (2005) |
“Pill in the pocket” strategy for atrial fibrillation treatment |
Abstract
PDF (Rus)
|
|
B. A. Tatarsky |
| |
| No 4 (2005) |
Enalapril therapy and thrombotic or inflammatory disturbances in essential arterial hypertension |
Abstract
PDF (Rus)
|
|
O. M. Moiseeva, O. A. Berkovich, S. V. Villevalde, I. V. Emelyanov |
| |
| No 2 (2005) |
Nebivolol influence on cardiovascular system and kidneys in post-partum arterial hypertension |
Abstract
PDF (Rus)
|
|
A. L. Vertkin, A. V. Barabashkina, O. N. Tkacheva, A. V. Vasilyeva, G. I. Kuntsevich, A. V. Lazarev, I. E. Mishina |
| |
| No 2 (2005) |
Disturbances of peripheral vascular reaction to vasoactive substances and hypotensive therapy efficacy |
Abstract
PDF (Rus)
|
|
G. I. Livshitz, A. A. Nikolaeva, K. Yu. Nikolaev |
| |
| No 2 (2005) |
Antianginal and antihypertensive efficacy of calcium antagonist cardilopin in patients with coronary heart disease and arterial hypertension |
Abstract
PDF (Rus)
|
|
O. A. Ivannikova, Yu. I. Zyablov |
| |
| No 1 (2005) |
New strategies in angioprotective therapy for patients with Type 2 diabetes mellitus and arterial hypertension |
Abstract
PDF (Rus)
|
|
A. S. Ametov, T. Yu. Demidova, S. A. Kosykh |
| |
| No 1 (2005) |
Valsartan and lisinopril influence on brachial artery endothelial function in patients with Q-wave acute myocardial infarction |
Abstract
PDF (Rus)
|
|
M. M. Kremkova, A. V. Grachev, B. A. Alyavi |
| |
| No 1 (2005) |
Hypotensive efficacy and cerebroprotective action of beta blocker metoprolol |
Abstract
PDF (Rus)
|
|
N. L. Afanasyeva, V. F. Mordovin, N. Yu. Efimova, G. V. Semke, I. Yu. Efimova |
| |
| No 4 (2004) |
Nebivolol in complex therapy of patients with coronary heart disease and chronic heart failure |
Abstract
PDF (Rus)
|
|
A. G. Yevdokimova, A. E. Radzevich, O. I. Tereshchenko, E. V. Kovalenko, T. A. Pichugina |
| |
| No 4 (2004) |
New, long-acting form of nifedipine: efficacy and safety in patients with mild to moderate arterial hypertension |
Abstract
PDF (Rus)
|
|
E. V. Alimova, S. Yu. Martsevich, V. M. Gorbunov, A. D. Deev, V. N. Khirmanov, L. A. Sokolova, V. I. Podzolkov, Yu. A. Karpov |
| |
| No 4 (2004) |
Therapeutic equivalence of two amlodipine preparations (original and generic) in patients with arterial hypertension. Results of a double-blind, randomized cross-over study |
Abstract
PDF (Rus)
|
|
S. Yu. Martsevich, N. P. Kutishenko, A. D. Deev, E. V. Alimova, Yu. E. Semenova |
| |
| 1 - 131 of 131 Items |
|
